These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16785130)

  • 1. Corticosteroids can reverse severe imatinib-induced hepatotoxicity.
    Ferrero D; Pogliani EM; Rege-Cambrin G; Fava C; Mattioli G; Dellacasa C; Campa E; Perfetti P; Fumagalli M; Boccadoro M
    Haematologica; 2006 Jun; 91(6 Suppl):ECR27. PubMed ID: 16785130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent imatinib-induced hepatotoxicity in a chronic myeloid leukaemia patient successfully managed with prednisone.
    Gupta S; Bhatt VR; Varma S
    BMJ Case Rep; 2011 Feb; 2011():. PubMed ID: 22707550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.
    Ikuta K; Torimoto Y; Jimbo J; Inamura J; Shindo M; Sato K; Tokusashi Y; Miyokawa N; Kohgo Y
    Int J Hematol; 2005 Nov; 82(4):343-6. PubMed ID: 16298828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity.
    Bilgi N; Bell K; Ananthakrishnan AN; Atallah E
    Ann Pharmacother; 2010 May; 44(5):926-8. PubMed ID: 20332334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological features of acute hepatitis after imatinib mesylate treatment.
    James C; Trouette H; Marit G; Cony-Makhoul P; Mahon FX
    Leukemia; 2003 May; 17(5):978-9. PubMed ID: 12750713
    [No Abstract]   [Full Text] [Related]  

  • 6. Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.
    Kong JH; Yoo SH; Lee KE; Nam SH; Kwon JM; Lee SM; Chang HJ; Choi MY; Cho MS; Mun YC; Nam E; Lee SN; Seong CM
    Acta Haematol; 2007; 118(4):205-8. PubMed ID: 18030002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A rare complication of imatinib mesylate therapy: drug-induced pneumonitis].
    Stakhina OV; Turkina AG; Kostina IE; Kochkareva IuB
    Ter Arkh; 2010; 82(2):59-61. PubMed ID: 20387680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis.
    Ohyashiki K; Kuriyama Y; Nakajima A; Tauchi T; Ito Y; Miyazawa H; Kimura Y; Serizawa H; Ebihara Y
    Leukemia; 2002 Oct; 16(10):2160-1. PubMed ID: 12357373
    [No Abstract]   [Full Text] [Related]  

  • 9. Imatinib mesylate-induced acute hepatitis with autoimmune features.
    Dhalluin-Venier V; Besson C; Dimet S; Thirot-Bibault A; Tchernia G; Buffet C
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1235-7. PubMed ID: 17033447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imatinib mesylate-induced acute cytolytic hepatitis].
    Rocca P; El Jastimi S; Troncy J; Scoazec JY; Boucher A; Vial T; Trépo C; Zoulim F
    Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 1):918-9. PubMed ID: 15523233
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated erythematous and pityriasiform plaques caused by imatinib mesylate.
    Pasmatzi E; Monastirli A; Matsouka P; Tsambaos D
    Acta Derm Venereol; 2003; 83(5):391-2. PubMed ID: 14609118
    [No Abstract]   [Full Text] [Related]  

  • 12. [Imatinib-induced toxic hepatitis: description of two cases and review of the literature].
    Fuster F; Medina L; Vallansot R; Granell M; Bruguera M
    Gastroenterol Hepatol; 2007 Nov; 30(9):525-30. PubMed ID: 17980129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis.
    Yamasawa H; Sugiyama Y; Bando M; Ohno S
    Respiration; 2008; 75(3):350-4. PubMed ID: 16449804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
    Campione E; Diluvio L; Paternò EJ; Di Marcantonio D; Francesconi A; Terrinoni A; Orlandi A; Chimenti S
    Clin Ther; 2009 Nov; 31(11):2565-9. PubMed ID: 20110001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe imatinib-induced hepatotoxicity].
    García Hernández FJ; González León R; Castillo Palma MJ; Sánchez Román J
    Med Clin (Barc); 2012 May; 138(14):638; author reply 638-9. PubMed ID: 22137996
    [No Abstract]   [Full Text] [Related]  

  • 16. Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
    Thia TJ; Tan HH; Chuah TH; Chow WC; Lui HF
    Singapore Med J; 2008 Mar; 49(3):e86-9. PubMed ID: 18362995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.
    Ikeda K; Shiga Y; Takahashi A; Kai T; Kimura H; Takeyama K; Noji H; Ogawa K; Nakamura A; Ohira H; Sato Y; Maruyama Y
    Leuk Lymphoma; 2006 Jan; 47(1):155-7. PubMed ID: 16321842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset imatinib mesylate-induced hepatotoxicity in a patient with gastrointestinal stromal tumors.
    Yachoui R
    Am J Ther; 2014; 21(5):e148-50. PubMed ID: 23567788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon syndromes and treatment manifestations of malignancy: Case 4. Periorbital edema and imatinib mesylate therapy for chronic myelogenous leukemia.
    Ramar K; Potti A; Mehdi SA
    J Clin Oncol; 2003 Jan; 21(1):172-3. PubMed ID: 12506189
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib mesylate (gleevec) hepatotoxicity.
    Mindikoglu AL; Regev A; Bejarano PA; Martinez EJ; Jeffers LJ; Schiff ER
    Dig Dis Sci; 2007 Feb; 52(2):598-601. PubMed ID: 17219077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.